
CAS 213411-83-7
:5-[4-[2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy]benzothien-7-ylmethyl]thiazolidine-2,4-dione
Description:
5-[4-[2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy]benzothien-7-ylmethyl]thiazolidine-2,4-dione, with CAS number 213411-83-7, is a synthetic organic compound characterized by its complex molecular structure, which includes a thiazolidine core, an oxazole moiety, and a benzothienyl group. This compound typically exhibits properties associated with thiazolidinediones, such as potential anti-inflammatory and antidiabetic activities, due to its ability to interact with peroxisome proliferator-activated receptors (PPARs). The presence of the oxazole and thiazolidine rings suggests that it may also possess unique electronic and steric properties, influencing its reactivity and biological activity. Additionally, the compound's solubility, stability, and interaction with biological systems can be affected by the substituents on the aromatic rings. As with many synthetic compounds, its pharmacological profile would require thorough investigation through in vitro and in vivo studies to fully understand its potential therapeutic applications and safety profile.
Formula:C24H20N2O4S2
InChI:InChI=1/C24H20N2O4S2/c1-14-18(25-23(30-14)15-5-3-2-4-6-15)9-11-29-19-8-7-16(21-17(19)10-12-31-21)13-20-22(27)26-24(28)32-20/h2-8,10,12,20H,9,11,13H2,1H3,(H,26,27,28)
SMILES:Cc1c(CCOc2ccc(CC3C(=NC(=O)S3)O)c3c2ccs3)nc(c2ccccc2)o1
Synonyms:- Bm-13.1258
- 5-({4-[2-(5-Methyl-2-Phenyl-1,3-Oxazol-4-Yl)Ethoxy]-1-Benzothiophen-7-Yl}Methyl)-1,3-Thiazolidine-2,4-Dione
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Edaglitazone
CAS:<p>Edaglitazone is a drug used for the treatment of type 2 diabetes. It belongs to the class of thiazolidinedione drugs, which are insulin sensitizers. Edaglitazone has shown anti-inflammatory properties and may be useful in treating inflammatory diseases such as rheumatoid arthritis. This drug can also be used as a diagnostic tool to measure insulin sensitivity in humans by measuring erythrocyte glucose uptake. Edaglitazone has been shown to inhibit tumor growth and induce apoptosis in cancer cells, but not healthy cells, in animal models.</p>Formula:C24H20N2O4S2Purity:Min. 95%Molecular weight:464.6 g/molEdaglitazone
CAS:<p>Edaglitazone (R-483) is a PPARγ agonist with antiplatelet activity that can be used in studies of diabetes and obesity.</p>Formula:C24H20N2O4S2Purity:98%Color and Shape:SolidMolecular weight:464.56


